NPCE Earnings Date: Nov 3, 2026 (Estimated) — NeuroPace, Inc.
NASDAQ · Healthcare · Medical Devices
Updated
When is NPCE's next earnings date?
NeuroPace, Inc. (NPCE) is expected to report earnings on Tuesday, November 3, 2026; the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.09 on revenue of $27.1M.
How did NPCE do in its last earnings report?
In its most recent report on Aug 11, 2026 (Q2 2026), NeuroPace, Inc. posted EPS of -$0.18 versus the -$0.22 estimate, a beat of 5.3%. Revenue was $22.8M against a $22.6M estimate. The stock's 1-day post-earnings move was -3.3%.
How much does NPCE stock move after earnings?
NPCE beat EPS estimates in 7 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 10.2% (up or down) in the day after earnings.
About NeuroPace, Inc.
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-11 | Q2 2026 | -0.22 | -0.18 | +5.26% | $22.8M | ✅ Beat | -3.26% | -3.85% | -7.84% |
| 2026-05-12 | Q1 2026 | -0.22 | -0.20 | +9.09% | $22.1M | ✅ Beat | +0.06% | +0.32% | +0.25% |
| 2026-03-03 | Q4 2025 | -0.15 | -0.08 | +46.67% | $26.6M | ✅ Beat | +0.87% | +2.82% | +1.74% |
| 2025-11-04 | Q3 2025 | -0.20 | -0.11 | +45.00% | $27.4M | ✅ Beat | +38.09% | +43.51% | +80.53% |
| 2025-08-12 | Q2 2025 | -0.23 | -0.26 | -13.04% | $23.5M | ❌ Miss | +2.08% | -9.64% | +9.64% |
| 2025-03-04 | Q4 2024 | -0.22 | -0.18 | +18.18% | $21.5M | ✅ Beat | -2.43% | -13.09% | +13.59% |
| 2024-11-12 | Q3 2024 | -0.27 | -0.19 | +29.63% | $21.1M | ✅ Beat | +28.15% | +28.57% | +52.80% |
| 2024-08-13 | Q2 2024 | -0.30 | -0.26 | +13.33% | $19.3M | ✅ Beat | -7.01% | -0.55% | -0.69% |
Showing last 8 quarters.